# OT-551 Antioxidant Eye Drops to Treat Geographic Atrophy in Age-Related Macular Degeneration

> **NCT00306488** · PHASE2 · COMPLETED · sponsor: **National Institutes of Health Clinical Center (CC)** · enrollment: 11 (actual)

## Conditions studied

- Geographic Atrophy
- Age-Related Macular Degeneration
- AMD

## Interventions

- **DRUG:** OT-551 antioxidant eye drop

## Key facts

- **NCT ID:** NCT00306488
- **Lead sponsor:** National Institutes of Health Clinical Center (CC)
- **Sponsor class:** NIH
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-03
- **Primary completion:** 2010-03
- **Final completion:** 2010-03
- **Target enrollment:** 11 (ACTUAL)
- **Last updated:** 2020-07-14

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00306488

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00306488, "OT-551 Antioxidant Eye Drops to Treat Geographic Atrophy in Age-Related Macular Degeneration". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00306488. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*